🇺🇸 Medroxyprogesterone Acetate 10 MG in United States

FDA authorised Medroxyprogesterone Acetate 10 MG on 18 June 1959

Marketing authorisations

FDA — authorised 18 June 1959

  • Application: NDA011839
  • Marketing authorisation holder: PFIZER
  • Local brand name: PROVERA
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Medroxyprogesterone Acetate 10 MG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Medroxyprogesterone Acetate 10 MG approved in United States?

Yes. FDA authorised it on 18 June 1959; FDA has authorised it.

Who is the marketing authorisation holder for Medroxyprogesterone Acetate 10 MG in United States?

PFIZER holds the US marketing authorisation.